686 related articles for article (PubMed ID: 24823790)
1. Pairwise polymer blends for oral drug delivery.
Marks JA; Wegiel LA; Taylor LS; Edgar KJ
J Pharm Sci; 2014 Sep; 103(9):2871-2883. PubMed ID: 24823790
[TBL] [Abstract][Full Text] [Related]
2. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
[TBL] [Abstract][Full Text] [Related]
3. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
4. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices.
Li B; Konecke S; Wegiel LA; Taylor LS; Edgar KJ
Carbohydr Polym; 2013 Oct; 98(1):1108-16. PubMed ID: 23987452
[TBL] [Abstract][Full Text] [Related]
5. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
6. The use of polymer blends to improve stability and performance of electrospun solid dispersions: The role of miscibility and phase separation.
Tipduangta P; Belton P; McAuley WJ; Qi S
Int J Pharm; 2021 Jun; 602():120637. PubMed ID: 33901595
[TBL] [Abstract][Full Text] [Related]
7. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics.
Karavas E; Georgarakis E; Bikiaris D
Eur J Pharm Biopharm; 2006 Aug; 64(1):115-26. PubMed ID: 16675210
[TBL] [Abstract][Full Text] [Related]
8. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
9. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
10. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
11. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion.
Van Ngo H; Nguyen PK; Van Vo T; Duan W; Tran VT; Tran PH; Tran TT
Int J Pharm; 2016 Nov; 513(1-2):148-152. PubMed ID: 27613254
[TBL] [Abstract][Full Text] [Related]
13. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
[TBL] [Abstract][Full Text] [Related]
14. Tailoring supersaturation from amorphous solid dispersions.
Li N; Taylor LS
J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
[TBL] [Abstract][Full Text] [Related]
15. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
[TBL] [Abstract][Full Text] [Related]
16. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
Pereira JM; Mejia-Ariza R; Ilevbare GA; McGettigan HE; Sriranganathan N; Taylor LS; Davis RM; Edgar KJ
Mol Pharm; 2013 Dec; 10(12):4640-53. PubMed ID: 24116899
[TBL] [Abstract][Full Text] [Related]
17. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
[TBL] [Abstract][Full Text] [Related]
18. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
19. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
20. Current Designs of Polymer Blends in Solid Dispersions for Improving Drug Bioavailability.
Tran PHL; Duan W; Lee BJ; Tran TTD
Curr Drug Metab; 2018; 19(13):1111-1118. PubMed ID: 29956619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
